, approximately 320,000 women are diagnosed with<unk>  worldwide each year and 76,000 die, making it the sixth most common<unk>  in women. It is more common in developed countries, where the lifetime risk of<unk>  in women is 1.6%, compared to 0.6% in developing countries. It occurs in 12.9 out of 100,000 women annually in developed countries. In the United States,<unk>  is the most frequently diagnosed gynecologic<unk>  and, in women, the fourth most common<unk>  overall, representing 6% of all<unk>  cases in women. In that country, it was estimated that 52,630 women were diagnosed yearly and 8,590 would die from the disease. Northern Europe, Eastern Europe, and North America have the highest rates of<unk> , whereas Africa and West Asia have the lowest rates. Asia saw 41% of the world's<unk>  diagnoses in 2012, whereas Northern Europe, Eastern Europe, and North America together comprised 48% of diagnoses. Unlike most<unk> s, the number of new cases has risen in recent years, including an increase of over 40% in the United Kingdom between 1993 and 2013. Some of this rise may be due to the increase in obesity rates in developed countries, increasing life expectancies, and lower birth rates. The average lifetime risk for<unk>  is approximately 2–3% in people with uteruses. In the UK, approximately 7,400 cases are diagnosed annually, and in the EU, approximately 88,000.<unk>  appears most frequently during perimenopause (the period just before, just after, and during menopause), between the ages of 50 and 65; overall, 75% of<unk>  occurs after menopause. Women younger than 40 make up 5% of<unk>  cases and 10–15% of cases occur in women under 50 years of age. This age group is at risk for developing ovarian<unk>  at the same time. The worldwide median age of diagnosis is 63 years of age; in the United States, the average age of diagnosis is 60 years of age. White American women are at higher risk for<unk>  than black American women, with a 2.88% and 1.69% lifetime risk respectively. Japanese-American women and American Latina women have a lower rates and Native Hawaiian women have higher rates.
Endometrial cancer
Cervical cancer
Uterine cancer
Ovarian cancer
Vaginal cancer
Breast cancer
Intravenous leiomyomatosis
Ovarian disease